Genetic tests offered by SpectraCell are a special piece of the clinical puzzle. The additional guidance this testing offers provides you with a truly personalized scope of preventive treatment. In addition to offering genetic markers for cardiovascular diseases (MTHFR), SpectraCell was the first lab to commercially offer Telomere Testing.
Mutations in this enzyme can affect the metabolism of homocysteine—causing accumulation—and therefore, impair methylation. Methylation is a biochemical process that is involved in numerous functions including cellular repair, energy production, detoxification, neurotransmitter production, and immunity, among others. MTHFR mutations have been linked to increased risk for cardiovascular disease, blood vessel damage, blood clots (thrombosis), stroke, and degenerative aging.